Zinzani, P. L.
, d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008).
Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer,
44(3), 366-73.
https://doi.org/10.1016/j.ejca.2007.12.008
Zinzani, P., Coiffier, B., Radford, J., Caballero, D., Fields, P., Chamuleau, M.
, D'Amore, F. A., Haioun, C., Thieblemont, C., Barca, E., Garcia, C., Johnson, PW., Van Imhoff, G., Saunders, A., Dwyer, K. & Morschhauser, F. (2014).
A phase II open-label, multi-center study of anti-CCR4 monoclonal antibody mogamulizumab (KW-0761) in patients with previously treated peripheral t-cell lymphoma (PTCL).
Blood,
124(21).
Zinzani, P. L., Karlin, L., Radford, J., Caballero, D., Fields, P., Chamuleau, M. E. D.
, d'Amore, F., Haioun, C., Thieblemont, C., González-Barca, E., Grande García, C., Johnson, P. W., van Imhoff, G. W., Ng, T., Dwyer, K. & Morschhauser, F. (2016).
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma.
Haematologica,
101(10), e407-e410.
https://doi.org/10.3324/haematol.2016.146977
Wulf, G. G., Altmann, B., Ziepert, M.
, D’Amore, F., Held, G., Greil, R., Tournilhac, O., Relander, T., Viardot, A., Wilhelm, M., Wilhelm, C., Pezzutto, A., Zijlstra, J. M., Neste, E. V. D., Lugtenburg, P. J., Doorduijn, J. K., Gelder, M. V., van Imhoff, G. W., Zettl, F. ... ACT-2 study investigators (2021).
Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.
Leukemia,
35(1), 143-155.
https://doi.org/10.1038/s41375-020-0838-5
Wästerlid, T., Brown, P. D. N., Hagberg, O., Hagberg, H., Pedersen, LM.
, D'Amore, F. A. & Jerkeman, M. (2013).
Impact of chemotherapy regimen and rituximab in adult Burkitt Lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Annals of Oncology,
24(7), 1879-1886.
Vase, M. Ø., Friis, S., Andrea
, Sørensen, H. T. & D'Amore, F. A. (2011).
Absence of anaplastic large cell lymphoma (ALCL) cases in a very large cohort of Danish women exposed to breast implants: results of a nationwide, population-based study. Blood,
118, 3689.
Vase, M. Ø., Hellberg, YK., Larsen, CS., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Nyvold, C. G., Christensen, M.
& D'Amore, F. A. (2011).
Development of splenic marginal zone lymphoma associated with active chronic visceral leishmaniasis. Blood,
118, 5202.
Vase, M. Ø., Hellberg, Y., larsen, C. S., Petersen, E., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Christensen, M.
& D'Amore, F. A. (2012).
Development of a splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica,
128(1), 20-22.
Vase, M. Ø., Hellberg, Y. K.
, Larsen, C. S., Petersen, E., Schaumburg, H., Bendix, K., Ravel, C., Bastien, P., Christensen, M.
& d'Amore, F. (2012).
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Acta Haematologica Polonica,
128(1), 20-2.
https://doi.org/10.1159/000337341
Vase, M. Ø., S, E. F., Bendix, K.
, Jespersen, B., Hamilton-Dutoit, S. J., Schwartz, S., Andersen, C.
& D'Amore, F. A. (2013).
Monomorphic PTLD in a danish cohort: HLA tissue subtype matching correlates with survival.
Hematological Oncology,
31, 216.
Vase, M. Ø.
, Larsen, C. S., Bendix, K.
, Hamilton-Dutoit, S. J., Moeller, M. B.
& D'Amore, F. A. (2013).
Hiv-associated lymphoma in Western Denmark: Higher frequency of Burkitt histology and primary extranodal non-CNS presentation in the post-as compared to the pre-HAART ERA.
Hematological Oncology,
31, 216-217.
Vase, M. Ø., Friis, S., Bautz, A., Bendix, K.
, Sørensen, H. T. & d'Amore, F. (2013).
Breast implants and anaplastic large cell lymphoma: A Danish population-based cohort study.
Cancer Epidemiology, Biomarkers & Prevention,
22(11), 2126-2129.
https://doi.org/10.1158/1055-9965.EPI-13-0633
Vase, M. Ø., Maksten, E. F., Bendix, K.
, Hamilton-Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J., Rabinovich, G. A.
, Søndergaard, E., Nielsen, P. S. & D'Amore, F. A. (2014).
Tumor microenvironmental features and outcome in post-transplant lymphoproliferative disorder.
Blood,
124(21).
Vase, M. Ø., Maksten, E. F., Bendix, K.
, Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, Søndergård, E., Nielsen, P. S. & D'amore, F. (2015).
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders.
Leukemia and Lymphoma,
56(6), 1677-85.
https://doi.org/10.3109/10428194.2014.966242
Vase, M. Ø., Maksten, E. F., Strandhave, C.
, Søndergaard, E., Bendix, K.
, Hamilton Dutoit, S. J., Andersen, C., Møller, M. B., Sørensen, S. S., Kampmann, J.
, Eiskjær, H., Iversen, M.
, Weinreich, I. D., Møller, B., Jespersen, B. & D'Amore, F. A. (2015).
HLA associations and risk of posttransplant lymphoproliferative disorder in Danish population-based cohort.
Transplantation Direct,
1(7), p e25.
https://doi.org/10.1097/TXD.0000000000000534
Vase, M. Ø.
, Ludvigsen, M., Bendix, K.
, Hamilton Dutoit, S. J., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., D'Amore, F. A. & Honoré, B. (2016).
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.
AIDS,
30(12), 1889-1898.
https://doi.org/10.1097/QAD.0000000000001152
Vase, M. Ø.
, Ludvigsen, M., Bendix, K.
, Dutoit, S. H., Hjortebjerg, R., Petruskevicius, I., Møller, M. B., Pedersen, G., Denton, P. W.
, Honoré, B., Rabinovich, G. A.
, Larsen, C. S. & d'Amore, F. (2017).
Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
AIDS,
31(16), 2311-2313.
https://doi.org/10.1097/QAD.0000000000001622
Vajavaara, H.
, Mortensen, J. B., Leivonen, S.-K.
, Hansen, I. M., Ludvigsen, M., Holte, H.
, Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021).
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma.
Cancers,
13(3), Article 398.
https://doi.org/10.3390/cancers13030398
Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182
Vähämurto, P., Pollari, M., Clausen, M. R.
, D’amore, F., Leppä, S. & Mannisto, S. (2020).
Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma.
Cancers,
12(7), Article 1967.
https://doi.org/10.3390/cancers12071967
Toft-Petersen, M.
, Kamper, P., Albertsen, S., Secher, L., Segel, EK., Clausen, M.
& D'Amore, F. A. (2011).
Monocytosis in the peripheral blood at first relapse/progression predicts poorer overall and progression-free survival after autologous hematopoietic stem cell transplantation in Hodgkin lymphoma. Blood,
118, 1559.
Strandhave, C.
, Jespersen, B., Jørgensen, KA., Schou, R.
, Søndergaard, E., Bendix, K., Mortensen, LS.
& D'Amore, F. A. (2011).
Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens.
Blood,
116(21), 5074.
Soerensen, J. F., Aggerholm, A., Kerndrup, G. B.
, Hansen, M. C., Ewald, I. K. L.
, Bill, M., Ebbesen, L. H.
, Rosenberg, C. A., Hokland, P., Ludvigsen, M. & Stidsholt Roug, A. (2020).
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Blood Advances,
4(5), 885-892.
https://doi.org/10.1182/bloodadvances.2019001157
Soerensen, J. F., Aggerholm, A., Rosenberg, C. A., Bill, M., Kerndrup, G. B., Ebbesen, L. H.
, Hansen, M. H., Roug, A. S. & Ludvigsen, M. (2022).
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Bone Marrow Transplantation,
57(3), 460-465.
https://doi.org/10.1038/s41409-022-01567-z
Sobrero, A., Muzzulini, C.
, d'Amore, F. A., Bogliolo, G., Massa, G., Ghio, R. & Pannacciulli, I. (1982).
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in mice.
Cancer Treatment Report,
66(12), 2061-70.
Snipsøyr, M. G.
, Wiggers, H., Knudsen, J. B.
, Ludvigsen, M., Poulsen, S. H., Petersen, E.
& Honoré, B. (2013).
Identification of putative, novel biomarkers for infective endocarditis by proteomic analysis. Poster session presented at 30th annual meeting of Nordic Society of Clinical Microbiology and Infectious Diseases, Aarhus, Denmark.
Snipsøyr, M. G.
, Ludvigsen, M., Petersen, E.
, Wiggers, H. & Honoré, B. (2016).
A systematic review of biomarkers in the diagnosis of infective endocarditis.
International Journal of Cardiology,
202, 564-570.
https://doi.org/10.1016/j.ijcard.2015.09.028
Snipsøyr, M. G.
, Wiggers, H., Ludvigsen, M., Stensballe, A., Vorum, H.
, Poulsen, S. H., Rasmussen, L. M., Petersen, E.
& Honoré, B. (2020).
Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis.
International Journal of Infectious Diseases,
96, 73-81.
https://doi.org/10.1016/j.ijid.2020.02.026
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TG. (1996).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Laboratory Investigation,
75((4)), 575-88.
Smir, BN., Hauke, RJ., Bierman, PJ., Gross, TG.
, d'Amore, F. A., Anderson, JR. & Greiner, TC. (1997).
Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Laboratory Investigation,
76((3)), 439.
Simonsen, A. T., Bill, M., Rosenberg, C. A., Hansen, M. H., Møller, P. L., Kjeldsen, E., Johansen, K. D.
, Ommen, H. B., Nederby, L.
, Aggerholm, A., Hokland, P. & Ludvigsen, M. (2020).
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
Leukemia Research,
92, Article 106350.
https://doi.org/10.1016/j.leukres.2020.106350
Rosenberg, C. A., Toft-Petersen, M., Linck, H., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2017).
Delineating distinct stages of early erythropoiesis in human bone marrow employing imaging flow cytometry. Abstract from Nordic Flow Cytometry Meeting, Copenhagen, Denmark.
Rosenberg, C. A., Bill, M., Rodrigues, M. A., Hauerslev, M., Kerndrup, G. B.
, Hokland, P. & Ludvigsen, M. (2021).
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics.
Cytometry. Part B: Clinical Cytometry,
100(5), 554-567.
https://doi.org/10.1002/cyto.b.21975
Rosenberg, C. A., Bill, M., Maguire, O., Petersen, M. A.
, Kjeldsen, E., Hokland, P. & Ludvigsen, M. (2022).
Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
Cytometry. Part B: Clinical Cytometry,
102(2), 107-114.
https://doi.org/10.1002/cyto.b.22035
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, D'Amore, F. A. & Aaltonen, L. (2015).
Identification of novel germline variants in early-onset familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-31.
Ristolainen, H., Kilpivaara, O.
, Kamper, P., Taskinen, M., Saarinen, S., Leppä, S.
, d'Amore, F. & Aaltonen, L. A. (2015).
Identification of homozygous deletion in ACAN and other candidate variants in familial classical Hodgkin lymphoma by exome sequencing.
British Journal of Haematology,
170(3), 428-431.
https://doi.org/10.1111/bjh.13295
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M.
& D'Amore, F. A. (2010).
favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01).
Blood,
116(21).
Relander, T.
, Pedersen, M. B., Ellin, F., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Holte, H., Österborg, A., Nully Brown, P. D., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Delabie, J., Sundström, C., Sander, B.
, Hamilton-Dutoit, S. J., Ehinger, M., Liestøl, K.
... d'Amore, F. A. (2022).
Long-Term Follow-up of Clinical Outcome Determinants and Correlative Biological Features from the Nordic NLG-T-01 Trial.
Blood,
140(Supplement 1), 1479–1480.
https://doi.org/10.1182
Petruskevicius, I.
, Ludvigsen, M., Kamper, P. M. H., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B., Honoré, B.
& D'Amore, F. A. (2014).
Galectin-1 as a novel prognostic biomarker in haematologic malignancies treated with non-myeloablative haemopoietic stem cell transplantation.. Poster session presented at European Group for Blood and Marrow Transplantation Annual Meeting, Milano, Italy.
Petruskevicius, I.
, Ludvigsen, M., Hjortebjerg, R.
, Sørensen, B. S., Kamper, P., Vase, M. Ø.
, Oestgaard, L. G., Nielsen, B.
, Honoré, B., Bjerre, M., Rabinovich, G. A.
& d'Amore, F. A. (2016).
Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative hemopoietic stem cell transplantation.
Bone Marrow Transplantation,
51(10), 1387-1390.
https://doi.org/10.1038/bmt.2016.127
Petruskevicius, I.
, Ludvigsen, M., Kamper, P., Hjortebjerg, R.
, Sørensen, B. S., Nielsen, B.
, Honoré, B. & d'Amore, F. A. (2014).
Galectin-1 as a novel biomarker in haematologic malignancies treated with non-myeloablative haematopoietic stem cell transplantation.
Petersen, M. A.
, Rosenberg, C. A., Brøndum, R. F.
, Aggerholm, A., Kjeldsen, E., Rahbek, O.
, Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022).
Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups.
British Journal of Haematology,
197(4), 452-466.
https://doi.org/10.1111/bjh.18094
Petersen, M. A.
, Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567
Pedersen, M. B., Zhao, Y., Arendrup, MC., Bendix, K., Bojsen-Møller, M., Mølle, I.
& D'Amore, F. A. (2011).
Co-existence of cerebral infection with Rhinocladiella mackenzei and primary central nervous system lymphoma in a HIV-negative patient.
Acta Pathologica et Microbiologica Scandinavica APMIS,
119(3), 221-223.